Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Last Updated: April 1, 2023

Details for New Drug Application (NDA): 020886

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

NDA 020886 describes PANRETIN, which is a drug marketed by Concordia and is included in one NDA. It is available from one supplier. Additional details are available on the PANRETIN profile page.

The generic ingredient in PANRETIN is alitretinoin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alitretinoin profile page.
Summary for 020886
Formulation / Manufacturing:see details
Pharmacology for NDA: 020886
Suppliers and Packaging for NDA: 020886
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PANRETIN alitretinoin GEL;TOPICAL 020886 NDA Concordia Pharmaceuticals Inc. 59212-601 59212-601-22 60 g in 1 TUBE (59212-601-22)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrengthEQ 0.1% BASE
Approval Date:Feb 2, 1999TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.